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ABSTRACT OF THE THESIS 
 
Investigating the Association Between Uncommon Exposures and Rare Disease Outcomes: 
an Application of a Simulation Approach to 
Extremely Low Frequency Magnetic Field (ELF-MF) and Childhood Leukemia 
 
By 
 
Fan Zhao 
 
Master of Science in Epidemiology 
University of California, Los Angeles, 2020 
Professor Leeka I. Kheifets, Chair 
 
Background: Studying risk factors of rare outcomes can be difficult as single studies tend to have 
few exposed cases, resulting in rather wide confidence intervals. Therefore, combination of 
multiple studies is usually necessary to draw a conclusion. Pooling of individual patient data (IPD) 
is considered the gold standard due to increased statistical power through large sample sizes and 
other advantages. However, present pooling is limited to studies of the same designs, which does 
not make full use of existing data.  
Objectives: To generalize pooling to studies of different designs (including cohort study, case 
control study, nested case control study and matched case control study), by incorporating 
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simulation of the association of extremely low frequency magnetic field (ELF-MF) and childhood 
leukemia.   
Method: I first simulated large cohort and case control samples based on parameters extracted 
from both the literature and existing large cohort and case control datasets, which included ELF-
MF exposure prevalence, childhood leukemia incidence rate, prevalence of confounders including 
age, gender, race and SES. Then I combined these simulated data using three different methods: 
two stage meta-analysis, one stage pooling and two stage meta-analysis with pooling. 
Results: Estimates from three synthesis methods were close to the causal estimate and there was 
no obvious trend of overestimation or underestimation. One stage pooling seemed to have the 
worst efficiency with the widest 95%CI but the difference was not significant. 
Conclusion: The performance of three synthesis methods in the study was not certain. Further 
simulations with varying parameters and possible mathematical derivations are needed to assess 
why and when these methods lead to different effect estimates. 
Keywords: Individual patient data (IPD); meta-analysis; pooling; simulation with R; Extremely 
Low Frequency Magnetic Field (ELF-MF); childhood leukemia 
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Investigating the Association Between Uncommon Exposures and Rare Disease Outcomes: 
an Application of a Simulation Approach to Extremely Low Frequency Magnetic Field 
(ELF-MF) and Childhood Leukemia 
 
Introduction 
Rare diseases are defined by the Rare Disease Act of 2002 as diseases affecting 200,000 
individuals or fewer in the United States. (1) Research on treatments or management strategies for 
rare diseases can be challenging primarily due to the limited number of individuals who will be 
eligible to participate in any given study, resulting in underpowered studies. (2,3) Therefore, 
combination of multiple studies is usually necessary to draw a conclusion.  
Traditional meta-analysis methods involve combining and analyzing aggregate data (usually 
obtained from published studies). (4) Pooling of individual participant data (IPD) has been 
considered the gold standard. (5) By standardization of data and analyses across studies, IPD 
removes potential sources of heterogeneity across studies and increases the statistical power and 
precision of estimates. (6–8) 
However, studies of rare outcome tend to be of different designs. (9) A case-control design is 
often necessary for studies investigating rare outcomes. Other possibilities include nested case 
control designs, nested prospective studies and prospective cohort designs. (9,10) To combine 
information from these studies with disparate designs is necessary to make full use of existing IPD 
and several authors proposed generalized pooling methods. Brumback et al. proposed two stage 
meta-analysis with maximum likelihood estimations (MLE). (11) In the Hormonal Factors in 
Breast Cancer collaborative study, researchers have implemented Mantel-Haenszel stratified two 
stage meta-analysis. (12) Ahlbom et al. selected a control group from the Finland cohort study, 
making it into matched case control study, and then pooled with other 8 case control studies. (13)  
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In this project, we show the relative performance of these generalized pooling methods applied 
to studies of different designs (including cohort studies, case control studies, nested case control 
studies and matched case control studies), by incorporating simulation of the association of 
extremely low frequency magnetic field (ELF-MF) on childhood leukemia. 
The investigation of the possible relation between magnetic field exposure and the occurrence 
of childhood cancer started with Wertheimer and Leeper’s study. (14) Using wire codes, increased 
cancer occurrence was found to be associated with occupancy in higher exposure homes. Although 
not provided in the paper, calculated point estimates of odds ratio (OR) were consistently in the 
2.0-3.0 range. However, this study has been criticized concerning exposure assessment, exposure 
misclassification by study investigators and absence of information on potential confounders such 
as maternal smoking or use of x-rays. (15) To address some of the shortcomings, others used field 
measurements, but these measurements were vulnerable to nonresponse bias. (16) The methods of 
subject identification and selection could also introduce bias. Controls tended to be more 
residentially stable compared with cases and the possibility that mobility patterns of cases are 
affected by the disease could bias the results in a manner that would not have been identifiable 
with the available data. (16) To address this, studies utilized calculated fields. (15,17,18) 
Due to the combination of an uncommon high exposure and a rare disease outcome, as well as 
possible confounding, exposure misclassification and selection bias by social economic status 
(SES) and mobility, epidemiologic evidence linking ELF-MF exposure to childhood leukemia 
appeared inconsistent, before the following pooled analyses were conducted.  Greenland et al. and 
Ahlbom et al. pooled the major epidemiological studies in 2000, and reported an increased 
childhood leukemia risk associated with ELF-MF exposure above 0.3 or 0.4 uT (OR=1.69, 95% 
CI 1.25-2.29; OR=2.00, 95% CI 1.27-3.13 respectively). (13,19) A pooled analysis of ELF-MF 
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and childhood leukemia studies published after 2000 had similar, albeit somewhat reduced risk 
(OR=1.44, CI 0.88-2.36 for above 0.3uT). (20)  
Given that some 40 epidemiologic studies have examined the relationship of magnetic fields or 
its surrogates and childhood leukemia, little can be gained from further repetition of investigations 
of risks at moderate and low exposure levels, unless such studies can be designed to test specific 
hypotheses, such as selection bias or aspects of exposure not previously captured. (21,22) New 
approaches are needed to elucidate this consistent, but small risk.  One such approach depends on 
the presence in some apartment buildings of indoor substations, adjacent to living areas. In some 
circumstances, the apartment immediately above (or next to) the substation can receive an elevated 
exposure from it. (23–28) Assembling a cohort of children who have lived in such buildings and 
comparing different apartments in the same building, which are expected to have similar socio-
economic characteristics, may be a way of avoiding socioeconomic bias, and assessing exposure 
without requiring subject participation. The study, known as “TransExpo,” will be feasible only as 
an international collaboration, because of the low prevalence of such exposure situations in any 
one country. (29) The attraction of TransExpo includes objective exposure assessment blind to 
case/controls status, avoidance of selection bias due to differential participation of cases and 
controls, some control of unidentified confounding, and subjects with high exposure. However, 
different designs are being used due to various limitations in the availability and quality of 
information in different countries. 
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Methods 
Aim 
The aim of this paper is to show the relative performance of one stage and two stage pooling of 
rare outcomes studies with different designs, based on the association of ELF-MF and childhood 
leukemia. 
Simulation set up 
I first simulated large cohort, nested case control and matched case control samples based on 
parameters extracted from both the literature and existing large cohort and case control datasets 
that included ELF-MF exposure and childhood leukemia incidence. To accommodate matched 
case control studies, I also included confounders as matching factors (for example, in some 
countries buildings with transformers in which cases lived are identified and controls are selected 
from the same buildings, i.e. matched on buildings). For the sake of simplicity, I only simulated a 
general confounding variable. I also assumed no measurement error and no selection bias.  
For the three cohort studies, I set sample sizes to 100,000, 500,000 and 1,000,000 with the same 
ELF-MF prevalence but they varied due to randomness. Childhood leukemia incidence was 0.05% 
among children and the prevalence of the confounder was 5%. I assumed that these variables 
followed the Bernoulli distributions. The simulation settings are presented in Table 1, based on the 
causal structure DAG (Figure 1). In particular, the probability of being exposed to ELF-MF was 
specified as: 
𝑃𝐸 =
exp⁡(𝛾0+𝛾𝐶𝐶)
1+exp⁡(𝛾0+𝛾𝐶𝐶)
 (1) 
Similarly, the probability of leukemia given the ELF-MF exposure and the confounder was 
specified as: 
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𝑃𝐷 =
exp⁡(𝛽0+𝛽𝐸𝐸+𝛽𝐶𝐶)
1+exp⁡(𝛽0+𝛽𝐸𝐸+𝛽𝐶𝐶)
 , where exp (𝛽𝐸) is interpreted as odds ratio (OR) (2) 
Featuring studies of rare outcome and exposure, it was often when there were no exposed cases 
in the above cohort simulations. Therefore, instead of sampling and selecting from cohort studies 
to get  nested case control and matched case control studies, which poses technical difficulties in 
data simulation, I manipulated the feature of case control studies that controls be representative of 
the total population in terms of exposure and covariates prevalence, and implemented the 
following simulation method. 
For nested case control studies, I first simulated the control arm with the same model (1) as the 
cohort to get the confounder as well as exposure. Then I calculated the prevalence of exposure and 
confounder in the case arm based on the following relationship with OR: 
𝑂𝑅 = exp⁡(𝛽𝐸) =
𝑙𝑜𝑔𝑂𝑑𝑑𝑠𝑐𝑎𝑠𝑒
𝑙𝑜𝑔𝑂𝑑𝑑𝑠𝑐𝑜𝑛𝑡𝑟𝑜𝑙
=
log⁡[𝑃𝐸−𝑐𝑎𝑠𝑒/(1−𝑃𝐸−𝑐𝑎𝑠𝑒)]
log⁡[𝑃𝐸−𝑐𝑜𝑛𝑡𝑟𝑜𝑙/(1−𝑃𝐸−𝑐𝑜𝑛𝑡𝑟𝑜𝑙)]
(3) 
I built 3 nested case control studies this way, with sample sizes of 1,000, 5,000 and 10,000, 
with equal numbers of cases and controls. 
Similarly, I simulated the control arm of matched case control studies based on the same model 
(1) as the cohort. Then I implemented 1:1 exact matching based on the confounder and calculated 
the prevalence of exposure in the case arm based on the equation (3). I built 3 matched case control 
studies this way, with sample sizes of 1,000, 5,000 and 10,000. 
All scenarios were simulated S=500 times. (Figure 2) And I repeated the above procedure with 
varying parameters for ELF-MF prevalence (1.5%, 3% and 5%) and OR (1.5, 3 and 5), resulting 
in 9 situations. I used statistical software R version 4.0.0 (the R Foundation for Statistical 
Computing, Vienna, Austria) to simulate and analyze our data. 
Random deviations of simulated studies from the true effect 
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Due to the random error of sampling, the effect estimates of ELF-MF on childhood leukemia 
[𝑂?̂? = exp⁡(𝛽𝐸)̂ ] from simulated studies may not be the same as the causal effect. Therefore, I 
also pooled the three cohort studies, nested case control and matched case control studies 
separately with mixed-effects logistic regression model to gauge the size of the random error. 
Table 1 Overview of Simulation Settings. 
 Scenarios 
Cohort study  
Confounding factor (C) Binary, C ∼Bernoulli(p); prevalence (Pc)=0.05 
ELF-MF (E)a Binary, E ∼Bernoulli(p); 𝛾𝐶=1.10; 𝛾0 varies. 
Leukemia (D)b Binary, D ∼Bernoulli(p); 𝛽𝐸varies; 𝛽𝐶=1.60; 𝛽0varies. 
Sample size (N) 100,000, 500,000 and 1,000,000 
Nested case control study  
Confounding factor (C) in the 
control arm 
Binary, C ∼Bernoulli(p); prevalence (Pc)=0.05 
ELF-MF (E)a in the control arm Binary, E ∼Bernoulli(p); 𝛾𝐶=1.10; 𝛾0 varies. 
ELF-MF (E)c in the case arm Binary, E ∼Bernoulli(p) 
Sample size (N) 1,000, 5,000 and 10,000 
Matched case control study  
Confounding factor (C) in the 
control arm 
Binary, C ∼Bernoulli(p); prevalence (Pc)=0.05 
ELF-MF (E)a in the control arm Binary, E ∼Bernoulli(p); 𝛾𝐶=1.10; 𝛾0 varies. 
ELF-MF (E)c in the case arm Binary, E ∼Bernoulli(p) 
Confounding factor (C) in the case 
arm 
Binary, C ∼Bernoulli(p); prevalence (Pc)=0.05 (the same as in 
the control arm). 
Sample size (N) 1,000, 5,000 and 10,000 
Number of simulations (S) 500 
OR = odds ratio; NCC= nested case control study; MCC=matched case control study. 
a𝑃(𝐸) =
exp⁡(𝛾0+𝛾𝐶𝐶)
1+exp⁡(𝛾0+𝛾𝐶𝐶)
, 1.5%, 3% and 5%. 
b𝑃(𝐷) =
exp⁡(𝛽0+𝛽𝐸𝐸+𝛽𝐶𝐶)
1+exp⁡(𝛽0+𝛽𝐸𝐸+𝛽𝐶𝐶)
, exp (𝛽𝐸)=1.5, 3 and 5. 
c 𝑃(𝐸)
1−𝑃(𝐸)
 in the case arm is equal to 𝑂𝑅 ×
𝑃(𝐸)
1−𝑃(𝐸)
 in the control arm. 
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Figure 1 Causal diagram illustrating causal structures under investigation. Gamma coefficients for 
association of confounder (C) and ELF-MF (E) and beta coefficients for effects of ELF-MF (E) on 
childhood leukemia (D) in equations 1 and 2. 
 
Methods for pooling analysis 
Two stage meta-analysis 
Effect estimates (ORs) were obtained for each study separately and then combined using a 
DerSimonian and Laird random-effects meta-analysis model. For this random-effects meta-
analysis model, I assumed that the studies have enough in common that it made sense to synthesize 
the information, but there is no reason to assume that they are ‘identical’ in the sense that the true 
effect size is exactly the same in all the studies. 
One stage pooling 
I sampled from cohort studies to make nested case control studies. I then pooled, in which data 
from all studies were entered simultaneously into a single mixed-effects logistic regression model 
with random intercepts for study. I broke the matching and adjusted for the matching factor. In 
this case, I assumed that baseline risk is different between studies, but still assumed that relative 
risks are same across studies. 
 
 
 
C 
E D 
𝛾𝐶 𝛽𝐶 
𝛽𝐸 
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Two stage meta-analysis with pooling 
I first pooled cohort studies, nested case control studies and matched case control studies 
separately, getting effect estimates for three types of studies and then combined them using a 
DerSimonian and Laird random-effects meta-analysis model. 
Performance measures 
I pooled nine studies with three methods and estimated the effect of ELF-MF on childhood 
leukemia [𝑂?̂? = exp⁡(𝛽𝐸)̂ ]. I assessed the variability between estimates from 500 simulation runs 
(i.e. the variation between different studies) by 2.5 and 97.5 percentiles of the 500 OR estimates. 
I also took it as a measure of efficiency. Bias of different methods was defined as the difference 
between the mean of 𝑂?̂? estimates based on 500 simulation runs and the true exposure effect OR, 
calculated as percentage change (
𝑂?̂?̅̅ ̅̅ −𝑂𝑅
𝑂𝑅
) × 100%. A negative bias indicates that the method 
underestimates the true underlying effect, and a positive bias indicates that the method 
overestimates the true underlying effect. I also assessed precision in estimates with the empirical 
standard error in the log scale, that is, the standard deviation of the 𝛽?̂? estimates across the samples, 
√
1
(𝑆−1)
∑ (?̂?ℎ − ?̅̂?)2
𝑆
ℎ=1 , where h is the hth simulation ranging from 1 to S and ?̅̂? is the empirical 
mean 𝛽?̂? of S simulations. The higher the SD, the higher the variability is and thus the lower the 
efficiency of the method is. 
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Figure 2 Simulation of the data and pooling. NCC: nested case control study; MCC: matched case control 
study. 
 
Result 
Pooled estimates from simulated cohorts, nested case controls and matched case controls were 
close to the causal estimates. (Figure 3, Appendix Table 1) Nested case control studies and 
matched case control studies were more efficient than cohort studies in that cohort studies had the 
widest 95%CI when the prevalence of exposure ELF-MF and OR were set. Measure by the width 
of 95%CI as well as standard error, the efficiency of nested case control studies and matched case 
control studies was similar. With the increase of exposure prevalence, efficiency improved in all 
Step 1: Basic setup. For the three cohort studies, sample sizes were 100,000, 500,000 and 
1,000,000. 
 
Step 2: Generation of confounding variable, exposure variable and outcome. 
 
Step 3: Simulated control arms in NCC and MCC, then case arms. Sample sizes were 1,000, 
5,000 and 10,000. 
 
Step 4: All scenarios were simulated 500 times. 
Step 6: Repeated with varying parameters for ELF-MF prevalence (1.5%, 3% and 5%) and 
OR (1.5, 3 and 5). 9 situations in total. 
Step 5: Pooled studies with three methods and extracted the evaluation parameters. 
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three study designs. On the contrary, with the decrease of OR to be closer to the null, efficiency 
improved in all three study designs. 
Estimates from three synthesis methods were close to the causal estimate and there was no 
obvious trend of overestimation or underestimation. One stage pooling seemed to have the worst 
efficiency with the widest 95%CI but the difference was not significant. Similar with pooled 
estimates from original simulated studies, as exposure prevalence increased, efficiency improved 
in all three synthesis methods. In contrast, as OR decreased to be closer to the null, efficiency 
improved in all three synthesis methods. (Figure 4, Appendix Table 2 and 3) 
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Figure 3 Pooled estimates from simulated cohorts, nested case controls and matched case controls, pooled 
with mixed-effects logistic regression model, with different combinations of ELF-MF prevalence (1.5%, 
3% and 5%) and OR (1.5, 3 and 5). 9 situations in total. 
12 
 
 
Figure 4 Estimates from three synthesis methods: two stage meta-analysis, one stage pooling and two stage 
meta-analysis with pooling, with different combinations of ELF-MF prevalence (1.5%, 3% and 5%) and 
OR (1.5, 3 and 5). 9 situations in total. 
 
Discussion 
The aim of this paper was to compare the relative performance of different methods to 
synthesize rare outcome studies of different designs. All three methods had similar point estimates, 
which were close to the causal estimate, but the one-stage pooling method where I first sampled 
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from cohort studies to make nested case control studies then pooled with mixed-effects logistic 
regression seemed to have the worst efficiency, measured by the widest 95%CI. But the difference 
was not significant and there was no essential difference among the three synthesis methods in 
terms of bias and precision. 
There are two statistical approaches for conducting an IPD meta-analysis: one-stage and two-
stage. The one-stage approach analyzes the IPD from all studies simultaneously, for example, in a 
hierarchical regression model with random effects. The two-stage approach derives aggregate data 
(such as effect estimates) in each study separately and then combines these in a traditional meta-
analysis model. (8) My first and second method corresponded to the two-stage and one-stage meta-
analysis. The two-stage approach is often preferred because in the second stage it uses standard 
meta-analysis methods that are well documented, for example, in the Cochrane Handbook. (30–
32) In my study, two-stage meta-analysis performed better in the sense of higher precision, 
whether I obtained the first stage estimates directly or by pooling. However, one-stage methods 
have also been recommended because they use a more exact likelihood specification, which avoids 
the assumptions of within-study normality and known within-study variances, which are especially 
problematic in meta-analyses with small studies and/or rare events. (33,34) Yet, one-stage methods 
are also criticized for being computationally intensive and prone to convergence problems. (34,35) 
Several authors have investigated the difference between one-stage and two-stage IPD meta-
analysis results, either empirically, theoretically or via simulation. (31,32,34,36–39) Most authors 
conclude that they give very similar results. However, differences can arise, and sometimes these 
may even be large with discrepant statistical or clinical significance. (34,40) Most differences 
between one-stage and two-stage approaches occur because of different modelling assumptions, 
including the specification of the likelihood and included parameters, the choice of fixed or random 
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effects and the utilization of correlation. In my study, the best choice of model specification and/or 
estimation method are unclear, therefore I implemented both one-stage and two-stage analyses and 
compared their results to check whether conclusions are the same. (8) In my two-stage meta-
analysis, I assumed that effect sizes in individual studies represent a random sample from a 
particular distribution of true effect. (41) The two-stage meta-analysis outperformed one-stage 
pooling in the sense of higher precision here. Further looking into the reasons is necessary. 
To my knowledge this is the first paper seeking to generalize pooling methods with simulation. 
Simulation methods are relatively straightforward once the assumptions of a model and the 
parameters to be used for data generation are specified. (42) 
There are several limitations of this simulation study that should be noted. First, due to hardware 
calculation capacity strains worsened by the rare exposure and outcome, I did not sample from 
cohorts to simulate nested case controls and matched case controls, which are the most common 
ways. Instead I utilized the quality that controls be representative of the total population in terms 
of exposure and covariates prevalence and simulated the control arms first. Then I simulated case 
arms based on the relationship with OR. Because this simulation method stuck to the qualities that 
were supposed to be achieved by nested case control and matched case control designs, I assumed 
this did not pose a big problem. And as was shown in Table 2 and Figure 3, pooled estimates from 
simulated cohorts, nested case controls and matched case controls centered around the causal 
estimates. Second, this study only simulated the simplest situation where there is only one binomial 
confounding variable but real-world data are much more complex and often do not adhere to the 
assumptions and parameters by which data are generated here. Therefore, I should further apply 
these pooling methods to real life data and compare results if possible. Third, it is practically 
impossible to know the values of true population parameters that are incorporated into current 
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simulation. For example, the regression coefficients ?̂? often may be unknown. Even if previous 
research provides empirically estimated parameter estimates, the exact value for these population 
parameters is still unknown due to sampling error. Also, in the study I set both the outcome and 
exposure to be rare (prevalence 0.05% and 1.5%-3% respectively), its generalization to study of 
other more common outcomes should be further studied. To deal with these, I can run simulations 
across a wider range of parameter values to understand how their models may perform under 
different conditions. Last, not all statistical questions require simulations to obtain meaningful 
answers. I cannot exclude the possibility that the pooling questions here can be answered through 
mathematical derivations. If that is the case, simulation studies can demonstrate only what was 
shown already to be true through mathematical proofs. (43) 
Appendix 
Table 1 Mean OR Estimates and 95%CI from Cohort, Nested Case Control and Matched Case Control 
Studies by Pooling. 
𝑂?̂?̅̅ ̅̅ (95%⁡𝐶𝐼)a OR=1.5 OR=3 OR=5 
P(E)=1.5% 1.4920 (1.3154-1.7267) 
1.5044 (1.3919-1.6362) 
1.4965 (1.3916-1.6160) 
2.9656 (2.6826-3.3049) 
2.9884 (2.7801-3.1994) 
2.9982 (2.7700-3.1997) 
4.9640 (4.5901-5.3840) 
5.0115 (4.6678-5.3949) 
4.9968 (4.6448-5.3091) 
P(E)=3% 1.4880 (1.3511-1.6298) 
1.5022 (1.4209-1.5917) 
1.5073 (1.4188-1.5920) 
2.9884 (2.7883-3.2340) 
2.9737 (2.8186-3.1163) 
3.0097 (2.8697-3.1598) 
4.9943 (4.7050-5.3295) 
4.9523 (4.7241-5.2006) 
4.9964 (4.7761-5.2350) 
P(E)=5% 1.5021 (1.4006-1.6358) 
1.4974 (1.4289-1.5656) 
1.5028 (1.4356-1.5682) 
2.9892 (2.8088-3.1998) 
2.9652 (2.8308-3.1077) 
3.0126 (2.9086-3.1284) 
4.9786 (4.6626-5.2670) 
4.9149 (4.7235-5.1083) 
5.0113 (4.8412-5.2017) 
In the cells are estimates of cohort studies, nested case control studies and matched case control studies in 
sequence. 
aeffect estimates of ELF-MF ≥0.4uT  on incidence of childhood leukemia of three simulated types of studies: 
cohort, nested case control and matched case control studies measured by 𝑂𝑅 = exp⁡(𝛽𝐸). Studies were 
pooled with mixed-effects logistic regression model, respectively.  95%CI is calculated as 2.5 and 97.5 
percentiles of the S=500 samples. 
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Table 2 Mean OR Estimates and 95% CI Yielded by Three Methods. 
𝑂?̂?̅̅ ̅̅ a (95% CIb) OR=1.5 OR=3 OR=5 
P(E)=1.5% 1.5105 (1.4282-1.5978)  
1.5179 (1.4270-1.6171) 
1.5054 (1.4155-1.6000) 
3.0106 (2.8701-3.1412) 
3.0543 (2.9159-3.2007) 
3.0074 (2.8621-3.1417) 
4.9923 (4.7674-5.2142) 
5.0855 (4.8456-5.3259) 
4.9928 (4.7635-5.2137) 
P(E)=3% 1.5052 (1.4485-1.5624) 
1.5134 (1.4618-1.5752) 
1.5011 (1.4451-1.5590) 
2.9843(2.8966-3.0879) 
3.0197(2.9145-3.1274) 
2.9816(2.8799-3.0891) 
4.9651 (4.8085-5.1184) 
5.0517 (4.8948-5.2217) 
4.9655 (4.8154-5.1248) 
P(E)=5% 1.5001 (1.4575-1.5436) 
1.5084 (1.4633-1.5550) 
1.4973 (1.4550-1.5409) 
2.9904 (2.9136-3.0708) 
3.0231 (2.9361-3.1087) 
2.9898 (2.9101-3.0696) 
4.9709 (4.8402-5.0983) 
5.0420 (4.8986-5.1900) 
4.9709 (4.8339-5.0987) 
In the cells are estimates of cohort studies, nested case control studies and matched case control studies in 
sequence. 
athe mean of the estimated effect of ELF-MF ≥0.4uT on incidence of childhood leukemia across the S=500 
simulated samples, measured by OR. 
b2.5 and 97.5 percentiles of the S=500 samples. 
 
Table 3 Efficiency and Bias Yielded by Three Methods. 
SDa (Biasb) OR=1.5 OR=3 OR=5 
P(E)=1.5% 0.0878 (-0.70%) 
0.0914 (-1.19%) 
0.0904 (-0.36%)  
0.0686 (-0.35%) 
0.0723 (-1.81%) 
0.0692 (-0.25%) 
0.0681 (0.15%) 
0.0729 (-1.71%) 
0.0669 (0.14%) 
P(E)=3% 0.0469 (0.30%)  
0.0664 (-1.38%)  
0.0434 (0.30%)  
0.0511 (0.52%) 
0.0537 (-0.66%) 
0.0519 (0.61%) 
0.0451 (0.70%)  
0.0469 (-1.03%) 
0.0425 (0.69%) 
P(E)=5% 0.0428 (-0.00%) 
0.0432 (-0.56%) 
0.0434 (0.18%) 
0.0405 (0.32%) 
0.0417 (-0.77%) 
0.0406 (0.34%) 
0.0384 (0.58%) 
0.0401 (-0.83%) 
0.0382 (0.58%) 
In the cells are estimates of cohort studies, nested case control studies and matched case control studies in 
sequence. 
athe standard deviation of the estimates across the S=500 samples. 
bthe bias as a percentage of effect of ELF-MF ≥0.4uT on incidence of childhood leukemia in simulations 
(OR=1.5, 3 and 5, respectively). Positive value means overestimates and negative means underestimates. 
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